Spellberg et al. found that, although Als3 immunization was equally effective as Als1 against disseminated candidiasis, it was highly effective than Als1 against both oropharyngeal and vaginal candidiasis, and induced a broader antibody response than the recombinant Als1 protein [204]. This evidence concerns the gene SOD1 and vulvovaginal candidiasis.